Basic Materials / Specialty ChemicalsNSE
$1809.70
+80.70 (+4.54%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 17%
FCF escenarios
weak_data · normalized FCF $-3.3B · quality 38.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
42/100
C
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$49.6B
P/E
165.1x
↑EV/EBITDA
42.9x
↑ROE
3.5%
↑Gross Margin
45.9%
↑Debt/Equity
1.71
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
+9.3%
FCF CAGR
—
FCF margin
-91.3%
FCF / Net income
-27.38x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $8.62B · net income $287.5M · FCF $-7.87B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $8.62B | $8.62B | $7.78B | $6.71B | $6.60B |
| Net Income | $287.5M | $287.5M | $348.3M | $356.5M | $499.7M |
| EBITDA | $1.44B | $1.44B | $1.26B | $1.13B | $1.11B |
| EPS | 10.90 | 10.90 | 13.20 | 13.96 | 20.03 |
| Gross Margin | 45.9% | 45.9% | 45.6% | 39.8% | 38.4% |
| Operating Margin | 12.7% | 12.7% | 14.0% | 13.0% | 14.4% |
| Net Margin | 3.3% | 3.3% | 4.5% | 5.3% | 7.6% |
| Balance Sheet | |||||
| Debt/Equity | 1.71 | 1.71 | 0.76 | 0.54 | 0.77 |
| Current Ratio | 1.17 | 1.17 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-7.87B | $-7.87B | $-1.22B | $-3.32B | $-1.34B |
| Returns | |||||
| ROE | 3.5% | 3.5% | 4.4% | 4.7% | 10.4% |
| Valuation | |||||
| P/E | 165.12 | 165.12 | 118.55 | 94.24 | 67.47 |
| EV/EBITDA | 42.89 | 42.89 | 37.33 | 33.12 | 33.55 |
| P/B | 5.85 | 5.85 | 5.23 | 4.42 | 6.99 |
| Growth & Yield | |||||
| Revenue Growth | 10.9% | 10.9% | 15.9% | 1.6% | — |
| EPS Growth | -17.4% | -17.4% | -5.4% | -30.3% | — |
| Dividend Yield | 0.1% | 0.1% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
145.1%
EPS terminal req.
$160.58
Spread vs growth
-162.6%
5Y implied EPS CAGR
77.9%
EPS terminal req.
$194.30
Spread vs growth
-95.3%
10Y implied EPS CAGR
39.9%
EPS terminal req.
$312.93
Spread vs growth
-57.3%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+6.5%
Start / end P/E
132.3x → 170.5x
EPS bridge
13.20 → 10.90
Residual
-5.0%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.